Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

337 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nippon Shinyaku : Launch of VyxeosⓇ Combination for I.V. Injection for the Treatment of High-risk AML in Japan
PU
Transcript : Jazz Pharmaceuticals plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM
ACELYRIN, INC. Announces Leadership Transition
GL
Transcript : Jazz Pharmaceuticals plc, Q1 2024 Earnings Call, May 01, 2024
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
PR
Nippon Shinyaku : Vyxeos® Combination for I.V. Injection Receives Approval for the Treatment of High-risk AML in Japan
PU
Acelyrin : Corporate Presentation
PU
Transcript : Jazz Pharmaceuticals plc - Special Call
Transcript : Jazz Pharmaceuticals plc Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 10:30 AM
Transcript : Jazz Pharmaceuticals plc, Q4 2023 Earnings Call, Feb 28, 2024
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance
PR
Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors
PR
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
PR
Transcript : Jazz Pharmaceuticals plc Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:15 PM
Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
Transcript : Jazz Pharmaceuticals plc, Q3 2023 Earnings Call, Nov 08, 2023
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
PR
Jazz Pharmaceuticals Announces Key Update to Leadership Team
AQ
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
AQ
Transcript : Jazz Pharmaceuticals plc, Q2 2023 Earnings Call, Aug 09, 2023
Nippon Shinyaku : Submission of New Drug Application for NS-87 (daunorubicin and cytarabine liposome injection) in Japan
PU
Transcript : Jazz Pharmaceuticals plc Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 03:20 PM
Transcript : Jazz Pharmaceuticals plc - Special Call
Transcript : Jazz Pharmaceuticals plc Presents at RBC Capital Markets Global Healthcare Conference 2023, May-16-2023 04:05 PM
Transcript : Jazz Pharmaceuticals plc, Q1 2023 Earnings Call, May 10, 2023
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
PR
Transcript : Jazz Pharmaceuticals plc Presents at Cowen 43rd Annual Healthcare Conference, Mar-07-2023 12:50 PM
Transcript : Jazz Pharmaceuticals plc, Q4 2022 Earnings Call, Mar 01, 2023
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance
PR
Transcript : Jazz Pharmaceuticals plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 03:45 PM
Jazz Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR
Transcript : Jazz Pharmaceuticals plc Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 01:50 PM
Transcript : Jazz Pharmaceuticals plc, Q3 2022 Earnings Call, Nov 09, 2022
Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point
PR
Jazz Pharmaceuticals : Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance - Form 8-K
PU
Transcript : Jazz Pharmaceuticals plc, Q2 2022 Earnings Call, Aug 03, 2022
Transcript : Jazz Pharmaceuticals plc Presents at Bank of America 2022 Healthcare Conference, May-10-2022 12:40 PM
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi (solriamfetol) to Axsome Therapeutics
AQ
Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics
PR
Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance
AQ
Transcript : Jazz Pharmaceuticals plc, Q1 2022 Earnings Call, May 04, 2022
Transcript : Radius Health, Inc. - Special Call
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi (solriamfetol) to Axsome Therapeutics
AQ
Jazz Pharmaceuticals : Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics - Form 8-K
PU
Axsome Therapeutics : to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience - Form 8-K
PU
Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing
AQ
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience
AQ
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics
PR
Jazz Pharmaceuticals : Needham Virtual Neuroscience Forum
PU
Transcript : Jazz Pharmaceuticals plc Presents at Needham Virtual Neuroscience Forum, Mar-16-2022 01:05 PM
No results for this search
  1. Stock Market
  2. Advanced search
  3. Bruce Cozadd
  4. News
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW